Related Experiment Video
Updated: Jun 11, 2025

Identifying Inhibitors of the HBx-DDB1 Interaction Using a Split Luciferase Assay System
Published on: December 21, 2019
Foxa deficiency restricts hepatitis B virus biosynthesis through epigenic silencing.
Rachel Matrenec1, Claudia E Oropeza1, Eddie Dekoven1
1Department of Microbiology and Immunology, College of Medicine, University of Illinois at Chicago, Chicago, Illinois, USA.
Targeting forkhead box A (Foxa) activity in the liver may resolve chronic Hepatitis B virus (HBV) infections. Reduced Foxa levels silence viral DNA methylation, halting HBV replication and offering a potential therapeutic strategy.
Area of Science:
- Hepatology
- Virology
- Molecular Biology
Background:
- Chronic Hepatitis B virus (HBV) infection lacks curative therapies, causing significant mortality.
- The small HBV genome limits drug targets, necessitating alternative therapeutic strategies like targeting host factors.
- Forkhead box A (Foxa) transcription factors are crucial for HBV replication in a mouse model.
Purpose of the Study:
- To investigate the role of Foxa transcription factors in HBV biosynthesis and identify potential therapeutic targets.
- To determine if manipulating Foxa activity can lead to the resolution of chronic HBV infection.
Main Methods:
- Utilized a Hepatitis B virus (HBV) transgenic mouse model of chronic infection.
- Generated liver-specific Foxa-deficient mice with varying Foxa gene expression (Foxa1, Foxa2, Foxa3).
- Assessed HBV transcription, replication, viral DNA methylation, and liver pathology.
Main Results:
- Liver-specific Foxa deficiency, particularly with Foxa3 expression, halted HBV replication but caused biliary epithelial hyperplasia.
- Expression of only Foxa1 or Foxa2 also restricted HBV replication with minimal liver pathology.
- The level of Foxa activity, not specific Foxa genes, determined HBV biosynthesis.
- Genetic Foxa deficiency induced CpG methylation and transcriptional silencing of HBV DNA.
Conclusions:
- Foxa activity is a key determinant of HBV biosynthesis.
- Therapeutic targeting of liver Foxa activity could induce HBV DNA methylation and transcriptional inactivation.
- This approach may lead to the resolution of chronic HBV infections.
More Related Videos
09:35Constitutive and Inducible Systems for Genetic In Vivo Modification of Mouse Hepatocytes Using Hydrodynamic Tail Vein Injection
Published on: February 2, 2018
09:35Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle
Published on: February 1, 2017
Related Concept Videos
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Viruses with RNA Genomes
Epigenetic Regulation
General Transcription Factors
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Cell Specific Gene Expression